Diabetic cardiomyopathy--a distinct disease?

Area of Science:

• Cardiology
• Endocrinology
• Molecular Biology

Background:

• Diabetes mellitus is a major risk factor for cardiovascular disease, particularly heart failure.
• Epidemiological studies confirm diabetes as an independent risk factor for heart failure, even after accounting for other risk factors.
• This has led to the concept of a distinct 'diabetic cardiomyopathy'.

Purpose of the Study:

• To review the evidence supporting the existence of diabetic cardiomyopathy.
• To explore the underlying cellular and molecular mechanisms of diabetic cardiomyopathy.
• To highlight the need for further clinical and translational research.

Main Methods:

• Review of epidemiological studies and experimental data.
• Analysis of proposed pathophysiological mechanisms, including oxidative stress and calcium handling.
• Identification of research gaps in clinical trials.

Main Results:

• Diabetic cardiomyopathy is characterized by a latent phase of diastolic dysfunction and left ventricular hypertrophy, preceding systolic failure.
• Experimental data support a direct myocardial insult in diabetes, leading to cellular, structural, and functional changes.
• Key mechanisms involve reactive oxygen species and altered intracellular calcium homeostasis.

Conclusions:

• Diabetic cardiomyopathy is a distinct clinical entity resulting from direct myocardial damage in diabetes.
• Understanding the hierarchy of disease mechanisms is crucial for identifying therapeutic targets.
• Further clinical studies and intervention trials are essential for developing specific pharmacotherapies to reduce cardiovascular morbidity and mortality in diabetic patients.